You are here

Copaxone

Teva shares slide as it faces illegal kickback charges from US government

Teva shares slide as it faces illegal kickback charges from US government

Pharmaforum

Teva Pharmaceutical

multiple sclerosis

Flag link:

U.S. sues Teva over alleged kickbacks for multiple sclerosis drug

U.S. sues Teva over alleged kickbacks for multiple sclerosis drug

Reuters

Teva Pharmaceutical

Flag link:

Teva Calls on FDA to Make Copaxone a Biologic as Part of March Transition

Teva Calls on FDA to Make Copaxone a Biologic as Part of March Transition

RAPS.org

Teva Pharmaceutical

multiple sclerosis

Flag link:

Teva forks over $54M to settle Copaxone, Azilect kickbacks suit

Teva forks over $54M to settle Copaxone, Azilect kickbacks suit

Fierce Pharma

Teva Pharmaceutgical

whistleblower lawsuit

Flag link:

Teva shares approach 20-year low amid Moody’s warning and other woes

Teva shares approach 20-year low amid Moody’s warning and other woes

Fierce Pharma

Teva Pharmaceutical

Flag link:

Dr. Reddy's Copaxone, NuvaRing generics derailed by FDA

Dr. Reddy's Copaxone, NuvaRing generics derailed by FDA

Fierce Pharma

Teva Pharmaceutical

Flag link:

Teva predicts bleak year ahead as generic, Copaxone sales drop

Teva predicts bleak year ahead as generic, Copaxone sales drop

Biopharma Dive

Teva Pharmaceutical

Flag link:

Mylan's generic Copaxone wins in court, but market barriers remain

Mylan's generic Copaxone wins in court, but market barriers remain

Biopharma Dive

Teva Pharmaceutical

multiple sclerosis

Flag link:

Here's Why Momenta Pharmaceuticals Tumbled 13.5% on Friday

Here's Why Momenta Pharmaceuticals Tumbled 13.5% on Friday

Motley Fool

Momenta Pharmaceuticals

Teva Pharmaceuticals

Flag link:

Gilenya beats Copaxone head-to-head at higher dose, study finds

Gilenya beats Copaxone head-to-head at higher dose, study finds

Biopharma Dive

Teva Pharmaceutical

Flag link:

Teva scoffs at whistleblowers' evidence in bid to dismiss kickbacks case

Teva scoffs at whistleblowers' evidence in bid to dismiss kickbacks case

Fierce Pharma

Teva Pharmaceutical

Flag link:

Teva stock drops 4.5% in spite of Q2 profit beat, revenue match

Teva stock drops 4.5% in spite of Q2 profit beat, revenue match

Marketwatch

Teva Pharmaceutical

Flag link:

A Look at Teva’s Earnings Estimates ahead of Q2 Results

A Look at Teva’s Earnings Estimates ahead of Q2 Results

Market Realist

Teva Pharmaceutical

Flag link:

Will Mylan’s big Copaxone price break force Teva’s hand? Clients are pushing already

Will Mylan’s big Copaxone price break force Teva’s hand? Clients are pushing already

Fierce Pharma

Teva Pharmaceuticals

Flag link:

Mylan decimates the list price of its Copaxone copy. But why?

Mylan decimates the list price of its Copaxone copy. But why?

Fierce Pharma

Flag link:

5 Best-Selling Orphan Drugs in the U.S.

5 Best-Selling Orphan Drugs in the U.S.

Motley Fool

Teva Pharmaceutical

Bristol-Myers Squibb

Flag link:

FDA Form 483 shows Pfizer repeating same mistakes at troubled fill-finish plant

FDA Form 483 shows Pfizer repeating same mistakes at troubled fill-finish plant

Fierce Pharma

drug manufacturing

Flag link:

Novartis, Momenta grab a delayed FDA OK for blockbuster Copaxone knockoff

Novartis, Momenta grab a delayed FDA OK for blockbuster Copaxone knockoff

Endpoints

Momenta Pharmaceuticals

Teva Pharmaceutical

multiple sclerosis

Flag link:

Will Teva Pharmaceutical's Pain Be Mylan's Gain?

Will Teva Pharmaceutical's Pain Be Mylan's Gain?

Motley Fool

Teva Pharmaceutical

multiple sclerosis

Flag link:

Teva's Turnarond: Is It Ever Or Never?

Teva's Turnarond: Is It Ever Or Never?

Forbes

Teva Pharmaceutical

Flag link:

Pages